NEWEarnings
CVS Health (CVS) Stock Rallies 3.7% on Analyst Upgrade
Published on 9/1/2026
AI Summary
Summarized by AI from the source belowCVS Health (CVS) shares increased as much as 3.7% on Tuesday morning, currently up 3.4%. This surge is attributed to a positive rating from Jefferies analyst Brian Tanquilut, who set a $120 price target indicating 28% upside. The forecast includes an expected earnings per share (EPS) of at least $8.44 for 2027. CVS's recent increase in full-year guidance suggests strong growth potential, making its stock appealing for investors monitoring healthcare sector movements.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
